Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome

被引:115
作者
Siegler, RL
Obrig, TG
Pysher, TJ
Tesh, VL
Denkers, ND
Taylor, FB
机构
[1] Dept Pediat, Div Pediat Nephrol & Hypertens, Salt Lake City, UT 84132 USA
[2] Univ Utah, Dept Pediat, Div Nephrol & Hypertens, Salt Lake City, UT USA
[3] Univ Utah, Dept Pathol, Div Pediat Pathol, Salt Lake City, UT USA
[4] Univ Virginia, Ctr Hlth Sci, Charlottesville, VA USA
[5] Texas A&M Univ, Ctr Hlth Sci, Dept Med Microbiol & Immunol, College Stn, TX USA
[6] Univ Oklahoma, Hlth Sci Ctr, Cardiovasc Biol Program, Oklahoma Med Res Fdn, Oklahoma City, OK USA
[7] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA
关键词
hemolytic uremic syndrome; shiga toxin 1; shiga toxin 2; primate model; animal model;
D O I
10.1007/s00467-002-1035-7
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Post-diarrheal (D+) hemolytic uremic syndrome (HUS) is caused by Shiga-toxin (Stx)-producing Escherichia coli. There is epidemiological, cell culture, and mouse model evidence that Stx2-producing E. coli are more likely to cause HUS than strains that produce only Stx1, but this hypothesis has not been tested in a primate model of HUS. We have developed a baboon model of Stx-mediated HUS that was employed to compare the clinical, cytokine, and histological response to equal amounts of the two Shiga toxins. Animals given IV Stx2 developed progressive thrombocytopenia, hemolytic anemia, and azotemia, and urinary interleukin-6 levels rose significantly. Glomerular thrombotic microangiopathy was found at necropsy. Animals given Stx1 showed no cytokine response and no clinical, laboratory, or histological signs of HUS. Our findings from the primate model corroborate previous epidemiological, cell culture, and mouse model observations, and suggest that enteric infection with Stx2-producing E. coli is more likely to cause HUS than infection with organisms that produce only Stx1.
引用
收藏
页码:92 / 96
页数:5
相关论文
共 27 条
[21]   Response to shiga toxin-1, with and without lipopolysaccharide, in a primate model of hemolytic uremic syndrome [J].
Siegler, RL ;
Pysher, TJ ;
Lou, R ;
Tesh, VL ;
Taylor, FB .
AMERICAN JOURNAL OF NEPHROLOGY, 2001, 21 (05) :420-425
[22]   Characterization of the baboon responses to Shiga-like toxin - Descriptive study of a new primate model of toxic responses to Stx-1 [J].
Taylor, FB ;
Tesh, VL ;
DeBault, L ;
Li, A ;
Chang, ACK ;
Kosanke, SD ;
Pysher, TJ ;
Siegler, RL .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (04) :1285-1299
[23]   Binding and transfer of verocytotoxin by polymorphonuclear leukocytes in hemolytic uremic syndrome [J].
te Loo, DMWM ;
Monnens, LAH ;
van der Velden, TJAM ;
Vermeer, MA ;
Preyers, F ;
Demacker, PNM ;
van den Heuvel, LPWJ ;
van Hinsbergh, VWM .
BLOOD, 2000, 95 (11) :3396-3402
[24]  
te Loo DMWM, 2001, J AM SOC NEPHROL, V12, P800, DOI 10.1681/ASN.V124800
[25]   COMPARISON OF THE RELATIVE TOXICITIES OF SHIGA-LIKE TOXINS TYPE-I AND TYPE-II FOR MICE [J].
TESH, VL ;
BURRIS, JA ;
OWENS, JW ;
GORDON, VM ;
WADOLKOWSKI, EA ;
OBRIEN, AD ;
SAMUEL, JE .
INFECTION AND IMMUNITY, 1993, 61 (08) :3392-3402
[26]  
TESH VL, 1994, RECENT ADV VEROCYTOT
[27]   ELIMINATION OF INTERLEUKIN-6 ATTENUATES COAGULATION ACTIVATION IN EXPERIMENTAL ENDOTOXEMIA IN CHIMPANZEES [J].
VANDERPOLL, T ;
LEVI, M ;
HACK, CE ;
TENCATE, H ;
VANDEVENTER, SJH ;
EERENBERG, AJM ;
DEGROOT, ER ;
JANSEN, J ;
GALLATI, H ;
BULLER, HR ;
TENCATE, JW ;
AARDEN, LA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (04) :1253-1259